Identification of Two Brain Cell Types That Shape Our Response to Smells

New research uncovers how specific brain cells in the amygdala influence whether we perceive smells as enjoyable or repulsive. Discover the neural basis of olfactory emotional responses and potential treatments for sensory sensitivities.
Researchers from the University of Florida have uncovered the neural mechanisms that determine whether a scent is perceived as pleasant or unpleasant. The study, published in "Molecular Psychiatry," reveals that specific brain cell types in the amygdala play a pivotal role in assigning emotional significance to odors. These cells, found in the basolateral amygdala (BLA), are genetically distinct and capable of influencing our emotional reactions toward smells, whether positive or negative.
Traditionally, it's been understood that smells exert a powerful influence on our emotions and memory, but the precise brain circuitry linking olfactory perception with emotional responses was not fully understood. The amygdala, a small yet key brain region responsible for processing emotions, receives direct input from the olfactory system, making it a crucial area for studying scent-related emotional responses.
Using mice models that share neurochemical similarities with humans, the team observed that these animals could learn to classify odors as appealing or repulsive. By examining their brain activity, the researchers identified two distinct cell types within the BLA—one expressing Drd1+ and the other Drd2+ receptors—that are responsible for mediating these emotional associations.
Interestingly, the findings suggest that these cells are not fixed in their role; instead, they possess the capability to produce either positive or negative emotional responses depending on where they project in the brain and how they interact with other neural structures. This flexibility means an odor's emotional valence is dynamically constructed rather than hardwired.
Understanding how the brain categorizes smells has significant implications, especially for individuals with heightened sensory sensitivities, such as those with PTSD, anxiety, or autism spectrum disorder. These individuals might experience exaggerated reactions to certain odors, affecting their daily lives. The research offers hope that future therapeutic strategies could target these specific neural pathways to modulate emotional responses to olfactory stimuli.
Potential treatments may involve medication or neural modulation techniques designed to suppress or activate these pathways, helping individuals gain control over adverse scent associations or restore enjoyment where it has been lost. Ultimately, this research advances our understanding of the biological basis of emotional processing related to our strongest sense and could lead to improved interventions for sensory-related emotional disorders.
Source: https://medicalxpress.com/news/2025-06-brain-cell-pleasant-unpleasant.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Machine Learning Enhances Diagnosis and Monitoring of Colorectal Cancer
A novel machine learning platform developed by researchers enhances the diagnosis and monitoring of colorectal cancer through metabolic biomarker analysis, offering a promising noninvasive approach to early detection and disease progression assessment.
How External Cues and Treatment Expectations Influence Pain Perception Differently, Study Shows
New research reveals that external cues and treatment expectations influence pain perception through different brain mechanisms, highlighting the importance of communication in pain management.
Strategies to Halt the Spread of HIV in the Southern United States
The Southern United States has become a new hotspot for HIV infections. Increased education, testing, and access to treatment are vital to curbing this growing epidemic. Learn more about effective strategies to stop HIV in the South.
Potential Risks of Taurine: Its Role in Promoting Leukemia Growth
Recent research uncovers the role of taurine in promoting leukemia growth by supporting cancer cell metabolism, highlighting the need for caution with taurine supplementation in at-risk individuals.